Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal

Leukemia Research

Volumn 33, Issue 3, 2009, Pages 391-394

  Breccia, M ^a   Latagliata, R ^a   Cannella, L ^a   Carmosino, I ^a   De Cuia, R ^a   Frustaci, A ^a   Stefanizzi, C ^a   Santopietro, M ^a   Alimena, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

FAB classification; Prognostic factors; RAEB; WHO criteria

Indexed keywords

HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; BLAST CELL; BLEEDING; BONE MARROW BIOPSY; CELL STRUCTURE; CLINICAL FEATURE; CYTOGENETICS; DATA BASE; DISEASE CLASSIFICATION; DYSPLASIA; ERYTHROBLAST; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION; KARYOTYPE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUTROPENIA; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA WITH EXCESS BLASTS; RISK ASSESSMENT; SURVIVAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UNIVARIATE ANALYSIS; WORLD HEALTH ORGANIZATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; CLASSIFICATION; DATABASES, FACTUAL; FEMALE; HEMOGLOBINS; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; PLATELET COUNT; PROGNOSIS; SURVIVAL RATE; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 58549085387     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.06.033     Document Type: Article

References (10)

1. Aul C., Bowen D.T., and Yoshida Y. Pathogenesis etiology and epidemiology of myelodysplastic syndromes. Haematologica 83 (1998) 71-86
2. Bennett J.M., Catowsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51 (1982) 189-199
3. Sanz G.F., Sanz M.A., Vallespi T., Canizo M.C., Torrabadella M., Garcia S., et al. Two regression models and scoring system for predicting survival and planning treatment in myelodysplastic syndromes. A multivariate analysis of prognostic factors in 370 patients. Blood 74 (1989) 395-408
4. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. J Clin Oncol 17 (1999) 3835-3849
5. Germing U., Gattermann N., Strupp C., Aivado M., and Aul C. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk Res 24 (2000) 983-992
6. Germing U., Strupp C., Kuendgen A., Aivado M., Giagounidis A., Hildebrandt B., et al. Refractory anemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals. Br J Haematol 132 (2005) 162-167
7. In: Mitelman F. (Ed). ISCN: an international system for human cytogenetic nomenclature (1995), Basel, Karger
8. Mufti G.J., Stevens J.R., Oscier D.G., Hamblin T.J., and Machin D. Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 59 (1985) 425-433
9. Greenberg P., Cox C., Le Beau M.M., Fenaux P., Morel P., Sanz G., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088
10. Malcovati L., Germing U., Kuendgen A., Della Porta M.G., Pascutto C., Invernizzi R., et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 25 (2007) 3503-3510